Food and Drug Administration targets Hims & Hers after telehealth company undercuts Novo Nordisk on obesity shot ...
According to DelveInsight's analysis, the primary sclerosing cholangitis market is anticipated to grow during the forecast period (2025--2034), driven by the launch of emerging therapies such as LB-P8 ...
SEOUL, South Korea, Feb. 5, 2026 /PRNewswire/ -- Sky Labs Inc. (CEO Jack Byunghwan Lee) announced on the 5th that it has ...
Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity February ...
Hims & Hers introduces a compounded version of Novo Nordisk's Wegovy pill at $49 monthly. Analysts react, raising concerns about market impact and legality amid Novo and Eli Lilly's share drops. With ...
Interpretation is the discipline through which molecular datasets reveal their significance. As the life sciences enter a new era defined by data richness and technological capacity, interpretive ...
Total net revenue of $15.2 million Adjusted EBITDA1 of $ (0.8) million, which includes EXXUA launch investments $30.0 million cash balance at December 31, 2025 Company launched EXXUA™ (gepirone) ...
The market for calcineurin inhibitor drugs is vital to modern healthcare infrastructure, supporting advances in transplant medicine and immunotherapy. The Calcineurin Inhibitor Drug Market supports ...
Track Trump’s January 2026 tariff timeline—chips, EU, Canada, Iran & more—and what it means for markets and S&P 500 ETFs.
West Pharmaceutical Services plans to move into the former BWI Group building, located at 989 Opportunity Parkway in Greenfield. A worldwide leader in injectable drug administration will be the newest ...
Issue: Whether, in a patent-infringement suit, a court may consider after-arising technology to hold that the patent is invalid under 35 U.S.C. § 112(a) of the Patent Act. Date Proceedings and Orders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results